You are here

  • Home
  • Archive
  • Volume 8, Issue 3
  • Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial

Article info

Article menu
Download PDFPDF
Review
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial

Authors

  • Tora S Solheim European Palliative Care Research Centre (PRC), Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway Cancer Clinic, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway PubMed articlesGoogle scholar articles
  • Barry J A Laird University of Edinburgh, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Trude R Balstad European Palliative Care Research Centre (PRC), Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway Cancer Clinic, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway PubMed articlesGoogle scholar articles
  • Asta Bye Department of Oncology, Regional Advisory Unit in Palliative Care, University Hospital, Oslo, Norway Faculty of Health Sciences, Department of Nursing and Health Promotion, Oslo and Akershus University College of Applied Sciences, Oslo, Norway PubMed articlesGoogle scholar articles
  • Guro Stene European Palliative Care Research Centre (PRC), Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway Cancer Clinic, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway PubMed articlesGoogle scholar articles
  • Vickie Baracos Department of Oncology, Division of Palliative Care Medicine, University of Alberta, Edmonton, Alberta, Canada PubMed articlesGoogle scholar articles
  • Florian Strasser Oncological Palliative Medicine, Clinic Medical Oncology and Haematology, Department of Internal Medicine, CantonalHospital, StGallen, Switzerland PubMed articlesGoogle scholar articles
  • Gareth Griffiths Southampton Clinical Trials Unit, University of Southampton, Southampton, UK PubMed articlesGoogle scholar articles
  • Matthew Maddocks King’s College London, Cicely Saunders Institute, London, UK PubMed articlesGoogle scholar articles
  • Marie Fallon University of Edinburgh, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Stein Kaasa European Palliative Care Research Centre (PRC), Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway Cancer Clinic, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway Oslo University Hospital and University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Kenneth Fearon University of Edinburgh, Edinburgh, UK Department of Surgery, Royal Infirmary, Edinburgh, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Barry J A Laird, University of Edinburgh, Edinburgh EH8 9YL, UK; barry.laird{at}ed.ac.uk
View Full Text

Citation

Solheim TS, Laird BJA, Balstad TR, et al
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
BMJ Supportive & Palliative Care 2018;8:258-265.

Publication history

  • Received October 4, 2017
  • Revision received November 16, 2017
  • Accepted December 13, 2017
  • First published February 9, 2018.
Online issue publication 
August 10, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.